FSGEX
Price
$14.76
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
TRIPX
Price
$22.79
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

FSGEX vs TRIPX

Header iconFSGEX vs TRIPX Comparison
Open Charts FSGEX vs TRIPXBanner chart's image
Fidelity Series Global ex US Index
Price$14.76
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Nuveen International Eq Idx Premier
Price$22.79
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
FSGEX vs TRIPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSGEX vs. TRIPX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSGEX is a Buy and TRIPX is a Buy.

FUNDAMENTALS
Fundamentals
FSGEX has more cash in the bank: 48.2B vs. TRIPX (26.9B). TRIPX (2.82) and FSGEX (2.77) have matching dividends . FSGEX was incepted earlier than TRIPX: FSGEX (15 years) vs TRIPX (15 years). FSGEX is a more actively managed with annual turnover of: 6.00 vs. TRIPX (5.00). FSGEX (0) and TRIPX (0) have matching initial minimum investment requirements. FSGEX annual gain was more profitable for investors over the last year : 13.84 vs. TRIPX (12.18). TRIPX (27.20) and FSGEX (26.49) have equivalent 5 years return.
FSGEXTRIPXFSGEX / TRIPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years15 years-
Gain YTD6.5704.398149%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets48.2B26.9B179%
Annual Yield % from dividends2.772.8298%
Returns for 1 year13.8412.18114%
Returns for 3 years1.491.7585%
Returns for 5 years26.4927.2097%
Returns for 10 years48.3242.48114%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DUOL323.439.10
+2.90%
Duolingo
CRVS8.890.20
+2.30%
Corvus Pharmaceuticals
ASNS1.390.01
+0.72%
Actelis Networks
CIA4.390.01
+0.23%
Citizens
CLBT17.80-0.79
-4.22%
Cellebrite DI Ltd